1 / 8

P.M. Rothwell, et al. Lancet 2005;366:29-36

Characteristics of patients included in the OCSP cohort used to derive the risk score and the three other cohorts used to validate the score. P.M. Rothwell, et al. Lancet 2005;366:29-36.

Download Presentation

P.M. Rothwell, et al. Lancet 2005;366:29-36

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Characteristics of patients included in the OCSP cohort used to derive the risk score and the three other cohorts used to validate the score P.M. Rothwell,et al. Lancet 2005;366:29-36

  2. Risk of stroke from time of presenting TIA in the two cohorts with probable or definite TIA and the two cohorts of all referrals with a preliminary diagnosis of suspected TIA P.M. Rothwell,et al. Lancet 2005;366:29-36

  3. 7-day risk of stroke after presenting TIA in relation to potential risk factors P.M. Rothwell,et al. Lancet 2005;366:29-36

  4. 7-day risk of stroke stratified according to ABCD score at first assessment in the OXVASC validation cohort of patients with probable or definite TIA P.M. Rothwell,et al. Lancet 2005;366:29-36

  5. ROC curves for predictive value of ABCD score in the three validation cohorts P.M. Rothwell,et al. Lancet 2005;366:29-36

  6. Multivariate Cox regression analysis of predictors of 7-day risk of stroke in patients with probable or definite TIA derived from the pooled data (stratified by study) from OCSP and OXVASC P.M. Rothwell,et al. Lancet 2005;366:29-36

  7. 7-day risk of stroke strati .ed according to ABCD score at first assessment in all referrals with suspected TIA to OXVASC and risk of stroke before scheduled clinic appointment in all referrals with suspected TIA to the non-OXVASC hospital-referred weekly TIA clinic P.M. Rothwell,et al. Lancet 2005;366:29-36

  8. Numbers of patients, numbers of strokes, and 7-day risks of stroke in all patients referred to OXVASC with suspected TIA stratified by clinical characteristics of presenting event, duration of event, and age P.M. Rothwell,et al. Lancet 2005;366:29-36

More Related